Takuto Kojima

Discovery of novel serine palmitoyltransferase inhibitors as cancer therapeutic agents.

Yuta Tanaka, B. Saito, Kazunobu Aoyama, 2018, Bioorganic & medicinal chemistry.

Discovery of 1,2,3,4-tetrahydropyrimido[1,2-a]benzimidazoles as novel class of corticotropin releasing factor 1 receptor antagonists.

Takahiko Yano, Yasutaka Hoashi, Y. Kosugi, 2018, Bioorganic & medicinal chemistry.

Pharmacological evaluation of a novel corticotropin‐releasing factor 1 receptor antagonist T‐3047928 in stress‐induced animal models in a comparison with alosetron

Takahiro Tanaka, T. Kawamura, Kozo Matsushita, 2020, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Useful reactions of silylated propargyltungsten or propargylmolybdenum species.

N. Iwasawa, T. Miura, Takuto Kojima, 2006, Angewandte Chemie.

Characterization of CRF1 receptor antagonists with differential peripheral vs central actions in CRF challenge in rats

K. Hirai, Takahiko Yano, K. Sakimura, 2017, Peptides.

Pneumatosis cystoides intestinalis following alpha-glucosidase inhibitor treatment

H. Kuroda, O. Kobayashi, M. Matsukawa, 2012 .

Capsule-Endoscopic Findings of Ulcerative Colitis Patients

Hirokazu Takahashi, A. Nakajima, K. Hosono, 2011, Digestion.

Antitumor activity of a novel and orally available inhibitor of serine palmitoyltransferase.

R. Adachi, Atsushi Kiba, M. Hirayama, 2017, Biochemical and biophysical research communications.

Identification of Novel, Potent, and Orally Available GCN2 Inhibitors with Type I Half Binding Mode.

M. Klein, R. Tjhen, Biching Sang, 2019, ACS medicinal chemistry letters.

Discovery of 4-chloro-2-(2,4-dichloro-6-methylphenoxy)-1-methyl-7-(pentan-3-yl)-1H-benzimidazole, a novel CRF1 receptor antagonist.

Takahiko Yano, Y. Kosugi, Hideyuki Nakagawa, 2017, Bioorganic & Medicinal Chemistry.

Hepatic portal venous gas development following percutaneous endoscopic gastrostomy.

M. Inamori, Takuto Kojima, Yuichiro Kadomatsu, 2013, Internal medicine.

Novel beta-Glucocerebrosidase Chaperone Compounds Identified from Cell-based Screening Reduce Pathologically Accumulated Glucosylsphingosine in iPS-derived Neuronal Cells.

Misaki Homma, Takuto Kojima, Maiko Tanaka, 2023, SLAS discovery : advancing life sciences R & D.